Treatment patterns and survival outcomes in patients with non-metastatic early-onset pancreatic cancer

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 12

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Mar 28, 2024; 30(12): 1739-1750
Published online Mar 28, 2024. doi: 10.3748/wjg.v30.i12.1739

Table 2 Treatment details based on clinical stage

Treatment	n (%)
Localized disease	215 (77.6)
Resection	204 (94.9)
Neoadjuvant and/or adjuvant therapy	124 (60.8)¹
Surgery alone	80 (39.2)
Nonsurgical therapy	11 (5.1)
Locally advanced disease	62 (22.4)
Surgery after neoadjuvant therapy	14 (22.6)
Radiotherapy-based combination therapy	29 (46.8)²
Chemotherapy	19 (30.6)

¹10 neoadjuvant therapy, 120 adjuvant therapy.

²6 intensity-modulated radiotherapy, 23 stereotactic body radiotherapy.

Citation: Zhang LT, Zhang Y, Cao BY, Wu CC, Wang J. Treatment patterns and survival outcomes in patients with non-metastatic early-onset pancreatic cancer. World J Gastroenterol 2024; 30(12): 1739-1750
URL: https://www.wjgnet.com/1007-9327/full/v30/i12/1739.htm
DOI: https://dx.doi.org/10.3748/wjg.v30.i12.1739

Zhang LT, Zhang Y, Cao BY, Wu CC, Wang J. Treatment patterns and survival outcomes in patients with non-metastatic early-onset pancreatic cancer. World J Gastroenterol 2024; 30(12): 1739-1750 [PMID: 38617739 DOI: 10.3748/wjg.v30.i12.1739]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.